“…For example, Qu et al, designed a heterogeneous palladium nanozyme that could effectively mediate the bioorthogonal reactions in situ through light and thus realized the specific imaging of mitochondria in living cells (Figures 2B,C). Beside CTCs and organelle imaging detection, there are also several other nanozymes-based colorimetric methods for specific disease imaging, including jaundice (Santhosh et al, 2014), acquired immune deficiency syndrome , diabetes (Tianran et al, 2014), infectious disease (Kim et al, 2014;Duan et al, 2015), and neurodegenerative disease (Wang C. I. et al, 2012;Farhadi et al, 2014). Thus, compared to traditional methods (such as PCR, cell flow cytometry, and ELISA), nanozymes methods exhibit more broaden prospect for live cell and organelle imaging because nanozyme assay is more fast, cost-effective and much easier to operate.…”